Close Menu
Bradley J . Monk, MD



School of Medicine
Obstetrics and Gynecology Residency
Arizona Health

Bradley J . Monk, MD



Obstetrics & Gynecology (Phoenix)




  • Journal of Clinical Oncology
    Del Campo JM, Matulonis UA, Malander S, Provencher D, Mahner S, Follana P, Waters J, Berek JS,Woie K, Oza AM, Canzler U, Gil-Martin M, Lesoin A, Monk BJ, Lund B, Gilbert L, Wenham RM,Benigno B, Arora S, Hazard SJ, Mirza MR. Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial. 2019
  • The Oncologist
    Arend RC, Toboni MD, Montgomery AM, Burger RA, Olawaiye AB, Monk BJ, Herzog TJ. Systemic treatment of metastatic/recurrent uterine leiomyosarcoma: A changing paradigm. 2018
  • Gynecologic Oncology Research and Practice
    Barnes D, Rivera R, Gibson S, Craig C, Cragun J, Monk B, Chase D. The utility of patient reported data in a gynecologic oncology clinic.
    Volume 5, Issue 4 2018
  • Gynecologic Oncology
    Chan JK, Brady W, Monk BJ, Brown J, Shahin MS, Rose PG, Kim JH, Secord AA, Walker JL, Gershenson DM. A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254).
    Volume 150, Issue 2, p. 247-252 2018